Jayson Donald Alexander Dallas insider trades: Arena Pharmaceuticals (ARNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jayson reports to the SEC




Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | ARNA | ↓ Sell | 1,223 | $66.36 | $81K | Direct | Jun 15, 2021 (0d) |
| Jan 19, 2021 | ARNA | ↓ Sell | 1,327 | $80.50 | $107K | Direct | Jan 20, 2021 (1d) |
| Dec 11, 2020 | ARNA | ↑ Buy | 5 | $69.31 | $347 | Direct | Dec 15, 2020 (4d) |
| Dec 8, 2020 | ARNA | ↑ Buy | 5 | $66.25 | $331 | Direct | Dec 9, 2020 (1d) |
| Mar 10, 2020 | AIMT | ↑ Buy | 2,665 | $18.74 | $50K | Direct | Mar 10, 2020 (0d) |
| Jun 14, 2019 | ARNA | ↓ Sell | 1,525 | $55.90 | $85K | Direct | Jun 17, 2019 (3d) |
| Nov 19, 2018 | AIMT | ↑ Buy | 3,650 | $27.56 | $101K | Direct | Nov 19, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jayson Donald Alexander Dallas's insider trades
Jayson Donald Alexander Dallas is a director at Arena Pharmaceuticals (ARNA). Since Nov 19, 2018, Jayson has reported 4 open-market purchases worth $151K and 3 sales worth $273K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), shares withheld for taxes (8 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.